https://oncodaily.com/drug/mobocertinib-exkivity-2026
Mobocertinib (Exkivity): Understanding Its Mechanism, Dosing, Clinical Development, and Role in...
Mobocertinib (Exkivity) is an oral, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor developed specifically for non-small cell...
clinical developmentmobocertinibexkivityunderstandingmechanism